Antisense therapy has generated waves of enthusiasm and disappointment. With a new drug about to be submitted for approval, is it on the cusp of becoming established as a platform technology?
Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
About this article
Journal of Experimental & Clinical Cancer Research (2018)
‘Dual’ peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNA
Future Virology (2017)
Development of a Method for Profiling Protein Interactions with LNA-Modified Antisense Oligonucleotides Using Protein Microarrays
Nucleic Acid Therapeutics (2016)
Future Medicinal Chemistry (2015)